Logo image of CVRX

CVRX INC (CVRX) Stock Fundamental Analysis

NASDAQ:CVRX - Nasdaq - US1266381052 - Common Stock - Currency: USD

7.24  +0.3 (+4.32%)

After market: 7.24 0 (0%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to CVRX. CVRX was compared to 187 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of CVRX have multiple concerns. CVRX is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

CVRX had negative earnings in the past year.
In the past year CVRX has reported a negative cash flow from operations.
In the past 5 years CVRX always reported negative net income.
CVRX had a negative operating cash flow in each of the past 5 years.
CVRX Yearly Net Income VS EBIT VS OCF VS FCFCVRX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -10M -20M -30M -40M -50M

1.2 Ratios

With a Return On Assets value of -39.78%, CVRX is not doing good in the industry: 64.71% of the companies in the same industry are doing better.
CVRX has a Return On Equity (-74.32%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -39.78%
ROE -74.32%
ROIC N/A
ROA(3y)-37.96%
ROA(5y)-32.85%
ROE(3y)-58.86%
ROE(5y)-49.03%
ROIC(3y)N/A
ROIC(5y)N/A
CVRX Yearly ROA, ROE, ROICCVRX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -500 -1K -1.5K

1.3 Margins

CVRX's Gross Margin of 83.44% is amongst the best of the industry. CVRX outperforms 94.12% of its industry peers.
In the last couple of years the Gross Margin of CVRX has grown nicely.
The Profit Margin and Operating Margin are not available for CVRX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 83.44%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.13%
GM growth 5Y2.79%
CVRX Yearly Profit, Operating, Gross MarginsCVRX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

More info and screens

3

2. Health

2.1 Basic Checks

CVRX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CVRX has been increased compared to 1 year ago.
Compared to 5 years ago, CVRX has more shares outstanding
The debt/assets ratio for CVRX is higher compared to a year ago.
CVRX Yearly Shares OutstandingCVRX Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
CVRX Yearly Total Debt VS Total AssetsCVRX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

CVRX has an Altman-Z score of -3.95. This is a bad value and indicates that CVRX is not financially healthy and even has some risk of bankruptcy.
CVRX's Altman-Z score of -3.95 is on the low side compared to the rest of the industry. CVRX is outperformed by 67.91% of its industry peers.
A Debt/Equity ratio of 0.71 indicates that CVRX is somewhat dependend on debt financing.
CVRX has a Debt to Equity ratio of 0.71. This is in the lower half of the industry: CVRX underperforms 71.66% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.71
Debt/FCF N/A
Altman-Z -3.95
ROIC/WACCN/A
WACC8.63%
CVRX Yearly LT Debt VS Equity VS FCFCVRX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

CVRX has a Current Ratio of 14.83. This indicates that CVRX is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 14.83, CVRX belongs to the top of the industry, outperforming 95.72% of the companies in the same industry.
CVRX has a Quick Ratio of 13.45. This indicates that CVRX is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of CVRX (13.45) is better than 95.72% of its industry peers.
Industry RankSector Rank
Current Ratio 14.83
Quick Ratio 13.45
CVRX Yearly Current Assets VS Current LiabilitesCVRX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 17.97% over the past year.
CVRX shows a strong growth in Revenue. In the last year, the Revenue has grown by 30.53%.
CVRX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 52.30% yearly.
EPS 1Y (TTM)17.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%12.31%
Revenue 1Y (TTM)30.53%
Revenue growth 3Y57.85%
Revenue growth 5Y52.3%
Sales Q2Q%15.1%

3.2 Future

The Earnings Per Share is expected to grow by 9.88% on average over the next years. This is quite good.
The Revenue is expected to grow by 20.86% on average over the next years. This is a very strong growth
EPS Next Y23.89%
EPS Next 2Y15.11%
EPS Next 3Y11.39%
EPS Next 5Y9.88%
Revenue Next Year10.19%
Revenue Next 2Y14.32%
Revenue Next 3Y13.99%
Revenue Next 5Y20.86%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
CVRX Yearly Revenue VS EstimatesCVRX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 20M 40M 60M 80M 100M
CVRX Yearly EPS VS EstimatesCVRX Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 -5 -10 -15 -20

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CVRX. In the last year negative earnings were reported.
Also next year CVRX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CVRX Price Earnings VS Forward Price EarningsCVRX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CVRX Per share dataCVRX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 -2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y15.11%
EPS Next 3Y11.39%

More info and screens

0

5. Dividend

5.1 Amount

CVRX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CVRX INC

NASDAQ:CVRX (8/8/2025, 8:00:00 PM)

After market: 7.24 0 (0%)

7.24

+0.3 (+4.32%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)08-04 2025-08-04/amc
Earnings (Next)10-27 2025-10-27/amc
Inst Owners69.78%
Inst Owner Change1.33%
Ins Owners4.28%
Ins Owner Change8.8%
Market Cap188.75M
Analysts80
Price Target11.83 (63.4%)
Short Float %7.54%
Short Ratio6.63
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1.65%
Min EPS beat(2)-12.12%
Max EPS beat(2)8.82%
EPS beat(4)1
Avg EPS beat(4)-9.81%
Min EPS beat(4)-19.26%
Max EPS beat(4)8.82%
EPS beat(8)4
Avg EPS beat(8)-9.24%
EPS beat(12)8
Avg EPS beat(12)-3.6%
EPS beat(16)10
Avg EPS beat(16)-5.64%
Revenue beat(2)0
Avg Revenue beat(2)-4.82%
Min Revenue beat(2)-9.51%
Max Revenue beat(2)-0.14%
Revenue beat(4)0
Avg Revenue beat(4)-3.05%
Min Revenue beat(4)-9.51%
Max Revenue beat(4)-0.14%
Revenue beat(8)2
Avg Revenue beat(8)-0.82%
Revenue beat(12)6
Avg Revenue beat(12)1.21%
Revenue beat(16)8
Avg Revenue beat(16)0.87%
PT rev (1m)0%
PT rev (3m)-31.4%
EPS NQ rev (1m)0%
EPS NQ rev (3m)5.06%
EPS NY rev (1m)0%
EPS NY rev (3m)2.15%
Revenue NQ rev (1m)0.04%
Revenue NQ rev (3m)-6.42%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-8.71%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.57
P/FCF N/A
P/OCF N/A
P/B 2.72
P/tB 2.72
EV/EBITDA N/A
EPS(TTM)-2.1
EYN/A
EPS(NY)-1.82
Fwd EYN/A
FCF(TTM)-1.59
FCFYN/A
OCF(TTM)-1.57
OCFYN/A
SpS2.03
BVpS2.66
TBVpS2.66
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -39.78%
ROE -74.32%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 83.44%
FCFM N/A
ROA(3y)-37.96%
ROA(5y)-32.85%
ROE(3y)-58.86%
ROE(5y)-49.03%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.13%
GM growth 5Y2.79%
F-Score4
Asset Turnover0.41
Health
Industry RankSector Rank
Debt/Equity 0.71
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 83.04%
Cap/Sales 1.06%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 14.83
Quick Ratio 13.45
Altman-Z -3.95
F-Score4
WACC8.63%
ROIC/WACCN/A
Cap/Depr(3y)167.13%
Cap/Depr(5y)316.6%
Cap/Sales(3y)2.41%
Cap/Sales(5y)4.28%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)17.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%12.31%
EPS Next Y23.89%
EPS Next 2Y15.11%
EPS Next 3Y11.39%
EPS Next 5Y9.88%
Revenue 1Y (TTM)30.53%
Revenue growth 3Y57.85%
Revenue growth 5Y52.3%
Sales Q2Q%15.1%
Revenue Next Year10.19%
Revenue Next 2Y14.32%
Revenue Next 3Y13.99%
Revenue Next 5Y20.86%
EBIT growth 1Y4.66%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year17.23%
EBIT Next 3Y9.14%
EBIT Next 5YN/A
FCF growth 1Y3.16%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y3.01%
OCF growth 3YN/A
OCF growth 5YN/A